Welcome to Emmes, a global full service clinical research organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation. Founded in 1977, Emmes has conducted over 2000 clinical studies across a broad range of therapeutic areas, with significant expertise in infectious diseases, vaccines, ophthalmology, oncology, neurology, substance use disorders, and maternal and child health.
Emmes resides at the intersection of the public and private healthcare sectors. This provides a unique value to our clients, as we are able to share innovations we learn from one client base to another. Experience in both the private and public clinical research communities combined with our longstanding strengths in biostatistics empowers us to help you with innovative study designs, regulatory strategies and full service global clinical trial execution capabilities.
We are proud of our contributions to public health. Emmes collaborates with biopharmaceutical, government, non-profit, and academic institutions to design and manage insightful clinical studies that impact millions of patients worldwide. From our work with the National Institutes of Health on rare diseases, gene and cell therapies, epidemics and pandemics to our ongoing relationships with biopharmaceutical companies and foundations, we are humbled by the contributions Emmes has made to organizations like yours.
Values drive us at Emmes; and as our name suggests, the quest for truth underscores everything we do. It guides the way we conduct research and the relationships we develop with clients. Through decades of experience we have learned that collaborative relationships thrive and human health benefits when truth is our compass.
We look forward to working with you.